$23MSeries A, 29 April 2026
Funds commercial rollout of its FDA-cleared HYPERSNAP system and wider clinical adoption.
- Amount
- $23M
- Stage
- Series A
- Announced
- 29 April 2026
- Lead
- Heal Capital
- Other investors
- Angelini Ventures, IP Group, Daycrest, Redalpine, Zeiss Ventures, LifeX Ventures, Heran Partners
- Use of funds
- Funds commercial rollout of its FDA-cleared HYPERSNAP system and wider clinical adoption.
- Checked
- Announced by the company
- Source
- Hypervision Surgical raises £17M Series A led by Angelini Ventures kcl.ac.uk